Lwl-Klinik Dortmund

Treatment & access

• Treatments offeredEsketamine nasal spray (Spravato®)
• Access routeTrial
• Cost & coverage (registry status)Free within clinical trial
• Websitehttps://www.lwl-klinik-dortmund.de

Languages spoken

As stated by the provider on its own website: each language links to the exact page and wording it was verified against.

• Turkish “Anka — Türkischsprachige Gruppentherapie für Menschen mit einer depressiven Störung” Source

Language information verified 2026-09-06.

About this provider

Compiled from the registry data on this page.

The EU Clinical Trials Information System (CTIS) records Lwl-Klinik Dortmund in Dortmund, Germany, as a site of trial 2023-506617-21-00: a randomised controlled trial of a six-week intensified pharmacological treatment for major depressive disorder, compared to treatment as usual, after a first-time failure of first-line treatment, sponsored by Universitair Medisch Centrum Utrecht. This directory lists the site for esketamine (Spravato); access is through participation in the trial, and treatment is free within the clinical trial. The CTIS public record is the registry source cited by this entry. The record was last verified on 2026-07-29.

What to prepare before you enquire

• A referral or the contact details of your treating clinician
• A list of medications you have tried (names, doses, duration)
• A short diagnosis summary or discharge letters

The research team confirms eligibility against your medical records at a screening visit.

Send documents directly to the provider when they reply. We never ask you to upload medical records.